rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2005-10-21
|
pubmed:abstractText |
Unstable coronary artery disease (CAD) is a multi-factorial disease involving thrombotic and inflammatory processes. Short-term low molecular weight (LMW) heparin treatment reduces coagulation activity and clinical events. We investigated the influence of prolonged treatment on coagulation, fibrinolysis and inflammation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0954-6820
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
258
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
420-7
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:16238677-Aged,
pubmed-meshheading:16238677-Anticoagulants,
pubmed-meshheading:16238677-Blood Coagulation,
pubmed-meshheading:16238677-C-Reactive Protein,
pubmed-meshheading:16238677-Coronary Artery Disease,
pubmed-meshheading:16238677-Dalteparin,
pubmed-meshheading:16238677-Double-Blind Method,
pubmed-meshheading:16238677-Drug Administration Schedule,
pubmed-meshheading:16238677-Female,
pubmed-meshheading:16238677-Fibrinogen,
pubmed-meshheading:16238677-Fibrinolysis,
pubmed-meshheading:16238677-Fibrinolytic Agents,
pubmed-meshheading:16238677-Humans,
pubmed-meshheading:16238677-Interleukin-6,
pubmed-meshheading:16238677-Male,
pubmed-meshheading:16238677-Prospective Studies,
pubmed-meshheading:16238677-Treatment Outcome,
pubmed-meshheading:16238677-von Willebrand Factor
|
pubmed:year |
2005
|
pubmed:articleTitle |
Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease.
|
pubmed:affiliation |
Department of Medical Sciences, Cardiology, Uppsala University Hospital, Uppsala, Sweden. jonas.oldgren@medsci.uu.se
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|